Keywords
Curation
Accueil
Racine
Curation
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration sur la maladie de Parkinson - Curation (Accueil)

Index « Keywords » - entrée « dopamine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
dopa. < dopamine < dopamine D1 receptor  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 74.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000001 (2011) D. S. Goldstein [États-Unis] ; P. Sullivan [États-Unis] ; C. Holmes [États-Unis] ; I. J. Kopin [États-Unis] ; M. J. Basile [États-Unis] ; D. C. Mash [États-Unis]Catechols in post‐mortem brain of patients with Parkinson disease
000022 (2007) Chen [États-Unis] ; Swope [États-Unis]Pharmacotherapy for Parkinson's Disease
000035 (2003) Stanley Fahn [États-Unis]Description of Parkinson's Disease as a Clinical Syndrome
000075 (1983) Bernard Scatton ; France Javoy-Agid [France] ; Liliane Rouquier ; Bruno Dubois [France] ; Yves Agid [France]Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease
000454 (2006) A. Lieberman [États-Unis]Depression in Parkinson's disease – a review
000476 (1998) C. S. Biggs [Royaume-Uni] ; A. Fisher [Royaume-Uni] ; M. S. Starr [Royaume-Uni]The antiparkinsonian drug budipine stimulates the activity of aromatic L‐amino acid decarboxylase and enhances L‐DOPA‐induced dopamine release in rat substantia nigra
000504 (2011) A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis]Milestones in neuroimaging
000507 (2010) David Devos [France] ; L. Defebvre [France] ; R. Bordet [France]Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease
000616 (2006) David W. Anderson [États-Unis] ; Kristin A. Bradbury [États-Unis] ; Jay S. Schneider [États-Unis]Neuroprotection in Parkinson models varies with toxin administration protocol
000643 (2004) Evelien Huisman [Pays-Bas] ; Harry B. M. Uylings [Pays-Bas] ; Piet V. Hoogland [Pays-Bas, Afrique du Sud]A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease
000646 (2011) T. Archer [Suède] ; A. Fredriksson [Suède] ; B. Johansson [Suède]Exercise alleviates Parkinsonism: clinical and laboratory evidence
000791 (1999) C. S. Biggs [Royaume-Uni] ; M. S. Starr [Royaume-Uni]Microdialysis study of the effects of the antiparkinsonian drug budipine on L‐DOPA‐induced release of dopamine and 5‐hydroxytryptamine by rat substantia nigra and corpus striatum
000851 (2002) J. Finsterer [Autriche]Parkinson syndrome as a manifestation of mitochondriopathy
000964 (2005) J. Eric Ahlskog [États-Unis]Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease
000970 (2011) Danielle M. Shore ; Robert Rafal ; John A. ParkinsonAppetitive motivational deficits in individuals with Parkinson's Disease
000972 (2001) S. Thobois [France] ; S. Guillouet [France] ; E. Broussolle [France]Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson’s disease
000A32 (2009) A. H. V. Schapira [Royaume-Uni] ; M. Emre [Turquie] ; P. Jenner [Royaume-Uni] ; W. Poewe [Autriche]Levodopa in the treatment of Parkinson’s disease
000B33 (2009) Ji E. Lee [Corée du Sud] ; Hae-Won Shin [Corée du Sud] ; Kyung S. Kim [Corée du Sud] ; Young H. Sohn [Corée du Sud]Factors contributing to the development of restless legs syndrome in patients with Parkinson disease
000B60 (2007) Andrew J. Lawrence [Royaume-Uni] ; Andrew D. Blackwell [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Francesca Spagnolo [Italie] ; Luke Clark [Royaume-Uni] ; Michael R. F. Aitken [Royaume-Uni] ; Barbara J. Sahakian [Royaume-Uni]Predictors of punding in Parkinson's disease: Results from a questionnaire survey
000C71 (2003) Andrea Carmine [Suède] ; Silvia Buervenich [Suède] ; Dagmar Galter [Suède] ; Erik G. Jönsson [Suède] ; Göran C. Sedvall [Suède] ; Lars Farde [Suède] ; J. Petter Gustavsson [Suède] ; Hans Bergman [Suède] ; Kodavali V. Chowdari [États-Unis] ; Vishwajit L. Nimgaonkar [États-Unis] ; Maria Anvret [Suède] ; Olof Sydow [Suède] ; Lars Olson [Suède]NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits
000D52 (2011) Ashley H. Spencer [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] ; Alfonso Fasano [Italie] ; Andrea E. Cavanna [Royaume-Uni]The prevalence and clinical characteristics of punding in Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/KwdEn.i -k "dopamine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/KwdEn.i  \
                -Sk "dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    dopamine
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024